These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 27247947)

  • 41. Targeting FGF21 in cardiovascular and metabolic diseases: from mechanism to medicine.
    Tan H; Yue T; Chen Z; Wu W; Xu S; Weng J
    Int J Biol Sci; 2023; 19(1):66-88. PubMed ID: 36594101
    [TBL] [Abstract][Full Text] [Related]  

  • 42. FGF21 attenuates hypoxia‑induced dysfunction and apoptosis in HPAECs through alleviating endoplasmic reticulum stress.
    Chen A; Liu J; Zhu J; Wang X; Xu Z; Cui Z; Yao D; Huang Z; Xu M; Chen M; Wu P; Li M; Wang L; Huang X
    Int J Mol Med; 2018 Sep; 42(3):1684-1694. PubMed ID: 29845288
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Overexpression of β-Klotho in Adipose Tissue Sensitizes Male Mice to Endogenous FGF21 and Provides Protection From Diet-Induced Obesity.
    Samms RJ; Cheng CC; Kharitonenkov A; Gimeno RE; Adams AC
    Endocrinology; 2016 Apr; 157(4):1467-80. PubMed ID: 26901091
    [TBL] [Abstract][Full Text] [Related]  

  • 44. FGF21 as a Hepatokine, Adipokine, and Myokine in Metabolism and Diseases.
    Itoh N
    Front Endocrinol (Lausanne); 2014; 5():107. PubMed ID: 25071723
    [TBL] [Abstract][Full Text] [Related]  

  • 45. TNF-α represses β-Klotho expression and impairs FGF21 action in adipose cells: involvement of JNK1 in the FGF21 pathway.
    Díaz-Delfín J; Hondares E; Iglesias R; Giralt M; Caelles C; Villarroya F
    Endocrinology; 2012 Sep; 153(9):4238-45. PubMed ID: 22778214
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Fibroblast growth factor 21 in cardio-metabolic disorders: a systematic review and meta-analysis.
    Lakhani I; Gong M; Wong WT; Bazoukis G; Lampropoulos K; Wong SH; Wu WKK; Wong MCS; Ong KL; Liu T; Tse G;
    Metabolism; 2018 Jun; 83():11-17. PubMed ID: 29410351
    [TBL] [Abstract][Full Text] [Related]  

  • 47. FGF21 and Chronic Kidney Disease.
    Salgado JV; Goes MA; Salgado Filho N
    Metabolism; 2021 May; 118():154738. PubMed ID: 33617873
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Klotho protects the heart from hyperglycemia-induced injury by inactivating ROS and NF-κB-mediated inflammation both in vitro and in vivo.
    Guo Y; Zhuang X; Huang Z; Zou J; Yang D; Hu X; Du Z; Wang L; Liao X
    Biochim Biophys Acta Mol Basis Dis; 2018 Jan; 1864(1):238-251. PubMed ID: 28982613
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Expression of Fibroblast Growth Factor 21 and β-Klotho Regulates Hepatic Fibrosis through the Nuclear Factor-κB and c-Jun N-Terminal Kinase Pathways.
    Lee KJ; Jang YO; Cha SK; Kim MY; Park KS; Eom YW; Baik SK
    Gut Liver; 2018 Jul; 12(4):449-456. PubMed ID: 29699061
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Physiology and Endocrinology Symposium: FGF21: Insights into mechanism of action from preclinical studies.
    Antonellis PJ; Kharitonenkov A; Adams AC
    J Anim Sci; 2014 Feb; 92(2):407-13. PubMed ID: 24398833
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The protective effect of FGF21 on diabetes-induced male germ cell apoptosis is associated with up-regulated testicular AKT and AMPK/Sirt1/PGC-1α signaling.
    Jiang X; Chen J; Zhang C; Zhang Z; Tan Y; Feng W; Skibba M; Xin Y; Cai L
    Endocrinology; 2015 Mar; 156(3):1156-70. PubMed ID: 25560828
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Role of ERK1/2 in the Development of Diabetic Cardiomyopathy.
    Xu Z; Sun J; Tong Q; Lin Q; Qian L; Park Y; Zheng Y
    Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27941647
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Fibroblast growth factor 21 protects against high glucose induced cellular damage and dysfunction of endothelial nitric-oxide synthase in endothelial cells.
    Wang XM; Song SS; Xiao H; Gao P; Li XJ; Si LY
    Cell Physiol Biochem; 2014; 34(3):658-71. PubMed ID: 25170746
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Multiple roles of fibroblast growth factor 21 in metabolism.
    Li LI; Tang L
    Curr Pharm Des; 2015; 21(21):3041-50. PubMed ID: 25675147
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Fibroblast growth factors in cardiovascular disease: The emerging role of FGF21.
    Domouzoglou EM; Naka KK; Vlahos AP; Papafaklis MI; Michalis LK; Tsatsoulis A; Maratos-Flier E
    Am J Physiol Heart Circ Physiol; 2015 Sep; 309(6):H1029-38. PubMed ID: 26232236
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Understanding the Physiology of FGF21.
    Fisher FM; Maratos-Flier E
    Annu Rev Physiol; 2016; 78():223-41. PubMed ID: 26654352
    [TBL] [Abstract][Full Text] [Related]  

  • 57. High-Level Serum Fibroblast Growth Factor 21 Concentration Is Closely Associated With an Increased Risk of Cardiovascular Diseases: A Systematic Review and Meta-Analysis.
    Zhang Y; Yan J; Yang N; Qian Z; Nie H; Yang Z; Yan D; Wei X; Ruan L; Huang Y; Zhang C; Zhang L
    Front Cardiovasc Med; 2021; 8():705273. PubMed ID: 34513950
    [No Abstract]   [Full Text] [Related]  

  • 58. [Fibroblast growth factor 21 plays a protective role in cardiovascular diseases by inducing autophagy].
    Li YK; He SY; Wang C; Shi YC; Liu JH
    Sheng Li Xue Bao; 2022 Aug; 74(4):633-638. PubMed ID: 35993214
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Fibroblast growth factor 21 night watch: advances and uncertainties in the field.
    Kharitonenkov A; DiMarchi R
    J Intern Med; 2017 Mar; 281(3):233-246. PubMed ID: 27878865
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Protective Effects of Fibroblast Growth Factor 21 Against Amyloid-Beta
    Amiri M; Braidy N; Aminzadeh M
    Neurotox Res; 2018 Oct; 34(3):574-583. PubMed ID: 29869772
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.